As of March 27, 2025, the initial public offering (IPO) of Shri Ahimsa Naturals Limited has concluded its subscription period, which was open from March 25 to March 27, 2025. The IPO aimed to raise approximately ₹73.81 crore, with a price band set between ₹113 and ₹119 per equity share

Subscription Status:

Overall Subscription: The IPO witnessed a subscription rate of approximately 4 times on its final day, indicating strong investor interest.

Retail Investors: The retail portion was subscribed 2.24 times, reflecting significant participation from individual investors

Non-Institutional Investors (NII): The NII segment saw a subscription rate of 3.73 times, highlighting robust demand from this category.

Qualified Institutional Buyers (QIB): There was no subscription from QIBs during this IPO.

Grey Market Premium (GMP):

In the grey market, unlisted shares of Shri Ahimsa Naturals were trading at a premium of ₹12, or approximately 10.8%, over the upper end of the issue price. This translates to a GMP of ₹131 per share, indicating positive market sentiment towards the IPO.

Company Financials:

For the financial year ending March 2024, Shri Ahimsa Naturals reported a net profit of ₹18.66 crore, a decrease of 51.15% from ₹38.2 crore in the previous fiscal year. The company's revenue from operations also declined by 24.9% to ₹78 crore in FY24, down from ₹103.9 crore in FY23. For the half-year ended September 30, 2024, the net profit stood at ₹9.74 crore. ​

Next Steps:

The allotment of shares is expected to be finalized on March 28, 2025. Investors can check their allotment status through the basis of allotment process. Shares allotted will be credited to demat accounts on March 31, 2025, with the listing on the NSE SME platform tentatively scheduled for April 2, 2025.

Please note that market conditions are subject to change, and it's advisable to consult financial advisors or official sources for the most current information.